Karmanos Recognitions

Michigan Cancer Consortium

The Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website. 

Goals of Consortium and its members include:

• Prevent cancer from occurring
• Promote early detection of cancer using tests that have been shown to reduce mortality
• Diagnose and treat all patients using the most effective and appropriate methods
• Optimize quality of life for every person affected by cancer